- $172.35m
- $167.26m
- $109.43m
Brief: Optimizerx Announces Multi-Year Agreement With Top Hub Services Provider To Accelerate Access For Patients
U.S. RESEARCH ROUNDUP-Etsy, Qualtrics International, Tcr2 Therapeutics
Brief: Optimizerx Reports Fourth Quarter And Full Year 2022 Financial Results
Optimizerx Corp Expected To Post Earnings Of 24 Cents A Share: Earnings Preview
Optimizerx Corp Expected To Post Earnings Of 24cents A Share: Earnings Preview
Brief: OptimizeRx Reports Third Quarter 2022 Financial Results
Optimizerx Corp Reports Results For The Quarter Ended In September: Earnings Summary
Optimizerx Corp Expected To Post Earnings Of 4cents A Share: Earnings Preview
Brief: Optimizerx Announces Strong Results From Its Use Of Previously Announced Ai/RWE Solution
Brief: OptimizeRx Extends Exclusive Partnership With Therapy Brands
Optimizerx Corp Reports Results For The Quarter Ended In June: Earnings Summary
Brief: Optimizerx Q2 GAAP Loss Per Share $0.21
Brief: OptimizeRx Extends Omnichannel Reach With Cooler Screens Partnership
U.S. RESEARCH ROUNDUP-Avalara, Citigroup, Rayonier Advanced Materials
U.S. RESEARCH ROUNDUP-Avalara, Citigroup, Rayonier Advanced Materials
Brief: OptimizeRx Extends Omni-Channel Platform Reach Through Partnership With Equals 5
Optimizerx Corp Reports Results For The Quarter Ended In March: Earnings Summary
Brief: OptimizeRx Reports First Quarter 2022 Financial Results
Optimizerx Corp Expected To Post A Loss Of 1 Cent A Share: Earnings Preview